Breakthrough Genetic Platform Targets Cancer With Engineered Virus Delivery
Calidi Biotherapeutics (NYSE American: CLDI) is developing a precision genetic medicine platform for cancer treatment. The company’s innovative approach focuses on using engineered viruses to deliver genetic medicines that can target both primary tumors and metastatic sites. The development comes amid concerning cancer statistics, with 20 million annual cancer diagnoses … Read more